CD44 expression in sinonasal melanomas: Is loss of isoform expression associated with advanced tumour stage?

Journal of Pathology

Volumn 187, Issue 2, 1999, Pages 184-190

  Regauer, Sigrid ^a,b   Ott, Arthur ^a   Berghold, Andrea ^a   Beham, Alfred ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

CD44; Cellular adhesion molecules; Head and neck; Medical oncology; Mucosal melanoma; Prognosis

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOMA CELL; NOSE TUMOR; PARANASAL SINUS TUMOR; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PROGNOSIS; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032956417     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199901)187:2<184::AID-PATH216>3.0.CO;2-2     Document Type: Article

References (43)

1. Harrison DFN. Malginant melanomata arising in the nasal mucous membrane. J Laryngol Otol 1976; 90: 993-1005.
2. Regauer S, Anderhuber W, Richtig E, et al. Primary mucosal melanomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 14 cases. APMIS 1998; 106: 403-410.
3. Kingdom TT, Kaplan MJ. Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 1995; 17: 184-189.
4. Franquemont DW, Stills SE. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol 1991; 96: 689-697.
5. Matias C, Corde J, Soares J. Primary malignant melanoma of the nasal cavity: a clinicopathologic study of nine cases. J Surg Oncol 1988; 39: 29-32.
6. Fernandez-Figueras MT, Ariza A, Calatrava A, et al. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma. J Cut Pathol 1996; 23: 133-139.
7. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12 160-12 164.
8. Tölg C, Hoffmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acid Res 1993; 21: 1225-1229.
9. Heider K-H, Hofmann M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-233.
10. Tuszynski GP, Wang TN, Berger D. Adhesive proteins and the hematogenous spread of cancer. Acta Hematol 1997; 97: 29-39.
11. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443-455.
12. Kaufmann M, Heider K-H, Sinn H-P, et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
13. Mulder JW, Kruyt P, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-1472.
14. Stauder R, Eisterer W, Thaler J, Günther U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognosic factor. Blood 1995; 85: 2885-2899.
15. Wielenga V, Heider KH, Offerhaus JG, et al. Expression of CD44 variant protein in human colorectal cancer is related to tumor progression. Cancer Res 1993; 54: 4754-4756.
16. Koopman G, Heider K-H. Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
17. van Muijen GNP, Danen EHJ, Veerkamp JH, et al. Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 1995; 61: 241-248.
18. Herbold KW, Zhou J, Haggerty JG, Milstone LM. CD44 expression on epidermal melanocytes. J Invest Dermatol 1996; 106: 1230-1235.
19. Manten-Horst E, Danen EH, Smit L, et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995; 64: 182-188.
20. Harwood CA, Green MA, Cook MG. CD44 expression in melanocytic lesions: a marker of malignant progression? Br J Dermatol 1996; 135: 876-882.
21. Seiter S, Schadendorf D, Tilgen W, Zöller M. CD44: prognostic relevance in different skin tumours. In: Head and Neck Cancer. Advances in Basic Research. Kiel: Elsevier, 1996.
22. Danen EH, ten-Berge PJ, Van-Muijen GN, et al. Expression of CD44 and the pattern of alternative splicing in uveal melanoma. Melanoma Res 1996; 6: 31-35.
23. Hermanek P, Henson DE, Hutter RVP, Sobin LH (eds). TNM Supplement 1993. Berlin: Springer-Verlag, 73-75.
24. Agresti A, In: Agresti A., ed. Categorical Data Analysis. 1st edn. New York: John Wiley, Interscience, 1990; 261-265.
25. Mayer B, Jauch KW, Günthert U, et al. De novo expression of CD44 and survival in gastric cancer. Lancet 1993; 342: 1019-1022.
26. Dall P, Heide KH, Hekeler A, et al. Surface protein expression and messenger RNA-splicing in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994; 54: 3337-3341.
27. Washimi O, Ueda R, Ariyoshi Y, et al. Expression of CD44 variant isoforms in normal and neoplaslic cells of the lung. Jpn J Cancer Res 1994; 85: 1112-1116.
28. Seiter S, Tilgen W, Herrman K, et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchous Arch 1996; 428: 141-149.
29. Müller W, Schneiders A, Heider KH, et al. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol 1997; 183: 222-227.
30. Shtivelman E, Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 1991; 11: 5446-5453.
31. Salmi M, Grön-Virta K, Sointu P, et al. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993; 122: 431-442.
32. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implications of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 1994; 54: 3922-3928.
33. Kallakury BVS, Yang F, Figge J, et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy. Cancer 1996; 78: 1461-1469
34. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996; 149: 873-882.
35. Gao AC, Lou W, Dong J-T, Isaacs JT. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997; 57: 846-849.
36. Goebler M, Kaufman D, Brocker EB, et al. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 1996; 109: 1957-1964.
37. Thomas L, Byers HR, Yink J, et al. CD44 H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 1992; 118: 971-977.
38. Faassen AE, Schrager JA, Klein DJ, et al. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 1992; 116: 521-531.
39. Peck D, Isacke CM. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Cur Biol 1996; 6: 884-890.
40. Camp RL, Kraus TA, Pure E. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol 1991; 115: 1283-1292.
41. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991; 3: 347-350.
42. Lesley J, Hyman R, Kincade P. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
43. Lacy BE, Underhill CB. The hyaluronate receptor is associated with actin filaments. J Cell Biol 1987; 105: 1395-1404.